These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 25865580)

  • 41. Transjugular intrahepatic portosystemic shunts in liver transplant recipients for management of refractory ascites: clinical outcome.
    Saad WE; Darwish WM; Davies MG; Waldman DL
    J Vasc Interv Radiol; 2010 Feb; 21(2):218-23. PubMed ID: 20123207
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Risk factors for short- and long-term mortality in liver transplant recipients with MELD score ≥30.
    Kaltenborn A; Hartmann C; Salinas R; Ramackers W; Kleine M; Vondran FW; Barthold M; Lehner F; Klempnauer J; Schrem H
    Ann Transplant; 2015 Jan; 20():59-69. PubMed ID: 25630462
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of Donor Age and Cold Ischemia on Liver Transplantation Outcomes According to the Severity of Recipient Status.
    Grąt M; Wronka KM; Patkowski W; Stypułkowski J; Grąt K; Krasnodębski M; Masior Ł; Lewandowski Z; Krawczyk M
    Dig Dis Sci; 2016 Feb; 61(2):626-35. PubMed ID: 26499986
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A high model for end-stage liver disease score should not be considered a contraindication to living donor liver transplantation.
    Poon KS; Chen TH; Jeng LB; Yang HR; Li PC; Lee CC; Yeh CC; Lai HC; Su WP; Peng CY; Chen YF; Ho YJ; Tsai PP
    Transplant Proc; 2012 Mar; 44(2):316-9. PubMed ID: 22410005
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Developments in pediatric liver transplantation since implementation of the new allocation rules in Eurotransplant.
    Herden U; Grabhorn E; Briem-Richter A; Ganschow R; Nashan B; Fischer L
    Clin Transplant; 2014 Sep; 28(9):1061-8. PubMed ID: 25040668
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Risk Assessment in High- and Low-MELD Liver Transplantation.
    Schlegel A; Linecker M; Kron P; Györi G; De Oliveira ML; Müllhaupt B; Clavien PA; Dutkowski P
    Am J Transplant; 2017 Apr; 17(4):1050-1063. PubMed ID: 27676319
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Is Muscle MELD a More Promising Predictor for Mortality After Living Donor Liver Transplantation?
    Badawy A; Kaido T; Hamaguchi Y; Anazawa T; Yagi S; Fukumitsu K; Kamo N; Okajima H; Uemoto S
    Prog Transplant; 2018 Sep; 28(3):213-219. PubMed ID: 29902957
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Predicting outcome after liver transplantation: utility of the model for end-stage liver disease and a newly derived discrimination function.
    Desai NM; Mange KC; Crawford MD; Abt PL; Frank AM; Markmann JW; Velidedeoglu E; Chapman WC; Markmann JF
    Transplantation; 2004 Jan; 77(1):99-106. PubMed ID: 14724442
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of pretransplant serum creatinine on the survival benefit of liver transplantation.
    Sharma P; Schaubel DE; Guidinger MK; Merion RM
    Liver Transpl; 2009 Dec; 15(12):1808-13. PubMed ID: 19938142
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Liver transplantation in acute-on-chronic liver failure patients with high model for end-stage liver disease (MELD) scores: a single center experience of 100 consecutive cases.
    Duan BW; Lu SC; Wang ML; Liu JN; Chi P; Lai W; Wu JS; Guo QL; Lin DD; Liu Y; Zeng DB; Li CY; Meng QH; Ding HG; Chen XY; Liao HY; Ma LQ; Chen Y; Zhang J; Xiang HP; Duan ZP; Li N
    J Surg Res; 2013 Aug; 183(2):936-43. PubMed ID: 23558257
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Liver transplant recipient selection: MELD vs. clinical judgment.
    Fink MA; Angus PW; Gow PJ; Berry SR; Wang BZ; Muralidharan V; Christophi C; Jones RM
    Liver Transpl; 2005 Jun; 11(6):621-6. PubMed ID: 15915491
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Are there better guidelines for allocation in liver transplantation? A novel score targeting justice and utility in the model for end-stage liver disease era.
    Dutkowski P; Oberkofler CE; Slankamenac K; Puhan MA; Schadde E; Müllhaupt B; Geier A; Clavien PA
    Ann Surg; 2011 Nov; 254(5):745-53; discussion 753. PubMed ID: 22042468
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MELD score versus conventional UNOS status in predicting short-term mortality after liver transplantation.
    Santori G; Andorno E; Morelli N; Antonucci A; Bottino G; Mondello R; Castiglione AG; Valente R; Ravazzoni F; Di Domenico S; Valente U
    Transpl Int; 2005 Jan; 18(1):65-72. PubMed ID: 15612986
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of the donor risk index on the outcome of hepatitis C virus-positive liver transplant recipients.
    Maluf DG; Edwards EB; Stravitz RT; Kauffman HM
    Liver Transpl; 2009 Jun; 15(6):592-9. PubMed ID: 19479802
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hepatic encephalopathy is associated with significantly increased mortality among patients awaiting liver transplantation.
    Wong RJ; Gish RG; Ahmed A
    Liver Transpl; 2014 Dec; 20(12):1454-61. PubMed ID: 25155379
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Short-term postliver transplant survival after the introduction of MELD scores for organ allocation in the United States.
    Yoo HY; Thuluvath PJ
    Liver Int; 2005 Jun; 25(3):536-41. PubMed ID: 15910490
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Higher graft-to-host ratio may decrease posttransplant mortality in patients with a high MELD score.
    Emiroglu R; Yilmaz U; Coskun M; Karakayali H; Haberal M
    Transplant Proc; 2007 May; 39(4):1164-5. PubMed ID: 17524921
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Model for End Stage Liver Disease score does not predict graft survival after living donor liver transplantation.
    Dulundu E; Sugawara Y; Kishi Y; Akamatsu N; Kaneko J; Makuuchi M
    Hepatogastroenterology; 2006; 53(71):781-2. PubMed ID: 17086888
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Split-liver transplantation in the high-MELD adult patient: are we being too cautious?
    Nadalin S; Schaffer R; Fruehauf N
    Transpl Int; 2009 Jul; 22(7):702-6. PubMed ID: 19254241
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Assessment of short-term survival after liver transplant by the Model for End-Stage Liver Disease.
    Buenadicha AL; Martín LG; Martín EE; Pajares Ad; Pérez AM; Seral CC; Marugán RB
    Transplant Proc; 2005 Nov; 37(9):3881-3. PubMed ID: 16386571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.